{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:24:35Z","timestamp":1791095075938,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2003,2,1]],"date-time":"2003-02-01T00:00:00Z","timestamp":1044057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,30]],"date-time":"2014-11-30T00:00:00Z","timestamp":1417305600000},"content-version":"vor","delay-in-days":4320,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2003,2]]},"DOI":"10.1046\/j.1469-0691.2003.00530.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T12:28:37Z","timestamp":1047385717000},"page":"79-85","source":"Crossref","is-referenced-by-count":128,"title":["Carbohydrate\u2014protein conjugate vaccines"],"prefix":"10.1016","volume":"9","author":[{"given":"G.","family":"Ada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Isaacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1046\/j.1469-0691.2003.00530.x_bib1","series-title":"The specificity of serological reactions","author":"Landsteiner","year":"1945"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib2","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1084\/jem.50.4.533","article-title":"Chemo-immunological studies on conjugated carbohydrate proteins. II. Immunological specificity of synthetic sugar protein antigen","volume":"50","author":"Avery","year":"1929","journal-title":"J Exp Med"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib3","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/S0264-410X(99)00232-7","article-title":"Glycoprotein conjugate vaccines","volume":"17","author":"Lindberg","year":"1999","journal-title":"Vaccine"},{"issue":"suppl 1","key":"10.1046\/j.1469-0691.2003.00530.x_bib4","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1093\/infdis\/165-Supplement_1-S49","article-title":"Thymus-independent and thymus\u2014dependent response to polysaccharide antigens","volume":"165","author":"Stein","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib5","series-title":"Vaccines","first-page":"183","article-title":"Haemophilus influenzae vaccines","author":"Ward","year":"1999"},{"issue":"suppl","key":"10.1046\/j.1469-0691.2003.00530.x_bib6","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1093\/infdis\/165-Supplement_1-S44","article-title":"T cell regulation of the antibody response to bacterial polysaccharide antigens: an examination of some general characteristics and their implications","volume":"165","author":"Baker","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib7","doi-asserted-by":"crossref","first-page":"7583","DOI":"10.1128\/IAI.69.12.7583-7587.2001","article-title":"Pneumococcal conjugate vaccines overcome splenic dependency of antibody response to pneumococcal polysaccharides","volume":"69","author":"Breukels","year":"2001","journal-title":"Infect Immun"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib8","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1128\/CDLI.4.2.168-172.1997","article-title":"Characterization of specific immunoglobulin G (IgG) and its subclasses (IgG1 and IgG2) against the 23-valent pneumococcal vaccine in a healthy adult population: proposal for response criteria","volume":"4","author":"Rodrigo","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib9","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.4049\/jimmunol.160.7.3412","article-title":"Stimulation of human T lymphocytes by LPS is MHC\u2014nonrestricted but strongly dependent on B7 interactions","volume":"160","author":"Mattern","year":"1998","journal-title":"J Immunol"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0065-2776(08)60400-9","article-title":"Immunoregulatory functions of \u03b3,\u03b4T cells","volume":"71","author":"Born","year":"1999","journal-title":"Adv Immunol"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib11","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1146\/annurev.immunol.18.1.975","article-title":"\u03b3,\u03b4Cells: a right time and a right place for a conserved third way of protection","volume":"18","author":"Hayday","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib12","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0167-5699(92)90068-I","article-title":"CD40 and its ligand, an essential ligand\u2014receptor pair for thymus\u2014dependent B cell activation","volume":"13","author":"Noelle","year":"1992","journal-title":"Immunol Today"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib13","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/(SICI)1521-4141(199803)28:03<1040::AID-IMMU1040>3.0.CO;2-9","article-title":"Cell division number regulates IgG1 and IgE switching of B cells following stimulation by CD40 ligand and IL-4","volume":"28","author":"Hasbold","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib14","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1542\/peds.85.4.654","article-title":"Immunogenicity to Haemophilus influenzae type b conjugate vaccines in children with conditions associated with impaired antibody responses to type b polysaccharide vaccine","volume":"85","author":"Weinberg","year":"1990","journal-title":"Pediatrics"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib15","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/infdis\/147.6.1100","article-title":"The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b","volume":"47","author":"Kayhty","year":"1983","journal-title":"J Infect Dis"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib16","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1542\/peds.60.5.730","article-title":"Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double\u2014blind field trial of 100,000 vaccinees 3 months to 5 years of age in Finland","volume":"60","author":"Peltola","year":"1977","journal-title":"Pediatrics"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1001\/jama.1993.03500020055031","article-title":"Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era","volume":"269","author":"Adams","year":"1993","journal-title":"JAMA"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib18","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1086\/517407","article-title":"Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization","volume":"177","author":"Goldblatt","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib19","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/0140-6736(92)92117-X","article-title":"Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunisation with conjugate vaccines","volume":"340","author":"Peltola","year":"1992","journal-title":"Lancet"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib20","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1056\/NEJM199710023371404","article-title":"Bacterial meningitis in the United States in 1995","volume":"337","author":"Schuchat","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib21","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/infdis\/164.5.982","article-title":"Reduction of oropharyngeal carriage of the Haemophilus influenzae type b (Hib) in children immunised with an Hib conjugate vaccine","volume":"164","author":"Takala","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/infdis\/171.1.93","article-title":"The impact of conjugate vaccine on carriage of Haemophilus influenzae type b","volume":"171","author":"Barbour","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib23","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(96)06392-1","article-title":"Vaccine failures after primary immunisation with Haemophilus influenzae type b","volume":"349","author":"Booy","year":"1997","journal-title":"Lancet"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib24","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0140-6736(92)90529-C","article-title":"Immunisation of infants in Iceland against Haemophilus influenzae type b","volume":"340","author":"Jonsdotir","year":"1992","journal-title":"Lancet"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib25","first-page":"101","article-title":"Pneumococcal vaccines","volume":"5","author":"Eskola","year":"1997","journal-title":"Clin Paediatr"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib26","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/infdis\/148.6.1136","article-title":"Consideration for formulating the second\u2014generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross\u2014reactive types within groups","volume":"148","author":"Robbins","year":"1983","journal-title":"J Infect Dis"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00006454-198601000-00008","article-title":"Antibody response to pneumococcal capsular polysaccharide vaccine in pre\u2014school age children","volume":"5","author":"Lievonen","year":"1986","journal-title":"Pediatr Infect Dis"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib29","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","article-title":"Efficacy of a pneumococcal conjugate vaccine against otitis media","volume":"344","author":"Eskola","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib30","first-page":"1360","article-title":"Polysaccharide vaccines of group A Neisseria meningitidis and Haemophilus influenzae type b: a field trial in Finland","volume":"174","author":"Makela","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib31","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/infdis\/175.1.200","article-title":"Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide\u2014protein conjugate vaccine","volume":"175","author":"Leach","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib32","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/jama.280.19.1685","article-title":"Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers. A randomized controlled trial","volume":"280","author":"MacDonald","year":"1998","journal-title":"JAMA"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0140-6736(00)03594-7","article-title":"Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England","volume":"357","author":"Ramsay","year":"2001","journal-title":"Lancet"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib34","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.1128\/IAI.67.11.5806-5810.1999","article-title":"Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam","volume":"67","author":"Kossaczkz","year":"1999","journal-title":"Infect Immun"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib35","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1056\/NEJM200104263441701","article-title":"The efficacy of a Salmonella typhi Vi conjugate vaccine in two- to fiveyear\u2014old children","volume":"344","author":"Lin","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib36","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1056\/NEJM198811033191802","article-title":"Immunisation of pregnant women with a polysaccharide vaccine of group B streptococcus","volume":"319","author":"Baker","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib37","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1128\/IAI.66.5.2186-2192.1998","article-title":"Structural properties of group B streptococcal type III polysaccharide conjugate vaccines that influence immunogenicity and efficacy","volume":"66","author":"Wessels","year":"1998","journal-title":"Infect Immun"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib38","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0264-410X(00)00226-7","article-title":"Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide\u2014cholera toxin B subunit conjugate vaccine for intranasal immunization","volume":"19","author":"Shen","year":"2000","journal-title":"Vaccine"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib39","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1128\/IAI.62.5.1593-1599.1994","article-title":"Functional antibodies to the group B streptococci elicited by a polysaccharide\u2014protein conjugate vaccine","volume":"62","author":"Marques","year":"1994","journal-title":"Infect Immun"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib40","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1086\/315839","article-title":"Use of capsular polysaccharide\u2014tetanus toxoid conjugate vaccine for type II group B streptococcus in healthy women","volume":"182","author":"Baker","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib41","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1128\/IAI.66.10.4588-4592.1998","article-title":"Antigenic determinants of Staphylococcus aureus type 5 and type 8 capsular polysaccharide vaccines","volume":"66","author":"Fattom","year":"1998","journal-title":"Infect Immun"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib42","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/0264-410X(95)00052-3","article-title":"Effect of conjugation methodology, carrier protein and adjuvants on the immune response to Staphylococcus aureus capsular polysaccharides","volume":"13","author":"Fattom","year":"1995","journal-title":"Vaccine"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib43","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMoa011297","article-title":"Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis","volume":"346","author":"Shinefield","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib44","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0264-410X(94)00009-C","article-title":"Synthesis and characterization of a polyvalent Escherichia coli Opolysaccharide\u2014toxin A conjugate vaccine","volume":"13","author":"Cryz","year":"1995","journal-title":"Vaccine"},{"key":"10.1046\/j.1469-0691.2003.00530.x_bib45","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1086\/324007","article-title":"Magnitude of interference after diphtheria\u2014tetanus\u2014acellular pertussis\/H. influenzae type b capsular polysaccharide\u2014tetanus vaccination is related to the number of doses administered","volume":"184","author":"Daum","year":"2001","journal-title":"J Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14629232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14629232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T04:19:28Z","timestamp":1704773968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14629232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,2]]}},"alternative-id":["S1198743X14629232"],"URL":"https:\/\/doi.org\/10.1046\/j.1469-0691.2003.00530.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2003,2]]}}}